SGLT2 Inhibition and Tubular Sodium Handling

1Internal Medicine, Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas 2Internal Medicine, Vice President for Research, Texas Tech Health Sciences Center, El Paso, Texas Correspondence: Dr. Biff F. Palmer, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Email: [email protected] See related editorial, “Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects,” on pages XXX–XXX.